drugset / Trial / NCT00376688
Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer
NaSingle-groupOpen-labelTreatment
Summary
This phase II trial studies how well temsirolimus works in treating patients with breast cancer that has spread to other places in the body. Temsirolimus may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Timeline
- Start
- 2006-07-11
- Primary completion
- 2008-06-12
- Completion
- 2019-12-16
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Temsirolimus | Small molecule | 25 mg | Intravenous |